Invention Application
US20160326261A1 MEANS AND METHODS FOR COUNTERACTING MYELOPROLIFERATIVE OR LYMPHOPROLIFERATIVE DISORDERS
审中-公开
逆转髓磷脂或淋巴细胞增多症的手段和方法
- Patent Title: MEANS AND METHODS FOR COUNTERACTING MYELOPROLIFERATIVE OR LYMPHOPROLIFERATIVE DISORDERS
- Patent Title (中): 逆转髓磷脂或淋巴细胞增多症的手段和方法
-
Application No.: US15105076Application Date: 2014-12-17
-
Publication No.: US20160326261A1Publication Date: 2016-11-10
- Inventor: Hergen SPITS , Tim BEAUMONT , Marijn Aletta GILLISSEN , Adrianus Quirinus BAKKER , Mette Deborah Hazenberg
- Applicant: AIMM THERAPEUTICS B.V.
- Priority: EP13197882.7 20131217
- International Application: PCT/NL2014/050873 WO 20141217
- Main IPC: C07K16/30
- IPC: C07K16/30 ; G01N33/574 ; C12P21/00 ; A61K47/48 ; C07K16/40
Abstract:
The invention provides human AML-specific binding compounds that are able to bind a cell surface component of AML cells. Therapeutic uses of binding compounds against AML are also provided.
Public/Granted literature
- US10556963B2 Means and methods for counteracting myeloproliferative or lymphoproliferative disorders Public/Granted day:2020-02-11
Information query
